Hourglass Capital’s Zimmer Biomet ZBH Stock Holding History

Hourglass Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.06M	Sell	78,055 -95	-0.1%	-$8.72K	1.47%	31
2025 Q4	$7.03M	Sell	78,150 -2,002	-2%	-$190K	1.52%	26
2025 Q3	$7.89M	Buy	80,152 +17,222	+27%	+$1.71M	1.77%	16
2025 Q2	$5.74M	Sell	62,930 -4,500	-7%	-$435K	1.42%	33
2025 Q1	$7.63M	Sell	67,430 -5	-0%	-$535	2%	13
2024 Q4	$7.12M	Buy	67,435 +21,560	+47%	+$2.31M	1.96%	18
2024 Q3	$4.95M	Buy	45,875 +1,625	+4%	+$177K	1.38%	35
2024 Q2	$4.8M	Buy	44,250 +25	+0.1%	+$2.95K	1.43%	35
2024 Q1	$5.84M	Sell	44,225 -100	-0.2%	-$12.5K	1.76%	23
2023 Q4	$5.39M	Buy	44,325 +41,425	+1,428%	+$4.62M	1.74%	27
2023 Q3	$325K	Hold	2,900	–	–	0.11%	82
2023 Q2	$422K	Hold	2,900	–	–	0.15%	77
2023 Q1	$375K	Hold	2,900	–	–	0.14%	78
2022 Q4	$370K	Hold	2,900	–	–	0.13%	80
2022 Q3	$303K	Hold	2,900	–	–	0.11%	87
2022 Q2	$305K	Hold	2,900	–	–	0.11%	88
2022 Q1	$371K	Sell	2,900 -87	-3%	-$10.5K	0.12%	84
2021 Q4	$368K	Hold	2,987	–	–	0.12%	85
2021 Q3	$424K	Hold	2,987	–	–	0.12%	84
2021 Q2	$466K	Sell	2,987 -412	-12%	-$66.7K	0.11%	101
2021 Q1	$528K	Hold	3,399	–	–	0.13%	94
2020 Q4	$508K	Sell	3,399 -206	-6%	-$29.1K	0.15%	89
2020 Q3	$476K	Sell	3,605 -34	-0.9%	-$4.44K	0.16%	82
2020 Q2	$422K	Hold	3,639	–	–	0.15%	84
2020 Q1	$357K	Hold	3,639	–	–	0.15%	79
2019 Q4	$529K	Hold	3,639	–	–	0.14%	75
2019 Q3	$485K	Sell	3,639 -412	-10%	-$53.2K	0.14%	75
2019 Q2	$463K	Sell	4,051 -1,030	-20%	-$121K	0.13%	71
2019 Q1	$630K	Hold	5,081	–	–	0.18%	60
2018 Q4	$512K	Hold	5,081	–	–	0.16%	72
2018 Q3	$649K	Hold	5,081	–	–	0.17%	64
2018 Q2	$550K	Hold	5,081	–	–	0.14%	68
2018 Q1	$538K	Sell	5,081 -412	-8%	-$47.8K	0.12%	73
2017 Q4	$644K	Sell	5,493 -56,101	-91%	-$6.34M	0.15%	71
2017 Q3	$7M	Buy	61,594 +257	+0.4%	+$29.7K	1.67%	29
2017 Q2	$7.65M	Sell	61,337 -442	-0.7%	-$52.4K	1.92%	18
2017 Q1	$7.32M	Sell	61,779 -83	-0.1%	-$9.41K	1.77%	20
2016 Q4	$6.2M	Sell	61,862 -7,756	-11%	-$831K	1.54%	29
2016 Q3	$8.79M	Sell	69,618 -1,122	-2%	-$139K	2.19%	14
2016 Q2	$8.27M	Sell	70,740 -3,384	-5%	-$383K	2.04%	15
2016 Q1	$7.67M	Buy	74,124 +2,850	+4%	+$276K	1.96%	17
2015 Q4	$7.1M	Sell	71,274 -1,169	-2%	-$114K	1.84%	19
2015 Q3	$6.61M	Buy	72,443 +11,402	+19%	+$1.14M	1.44%	28
2015 Q2	$6.47M	Sell	61,041 -154	-0.3%	-$17K	1.02%	40
2015 Q1	$6.98M	Sell	61,195 -614	-1%	-$70.1K	1.05%	30
2014 Q4	$6.81M	Sell	61,809 -2,987	-5%	-$315K	1.22%	32
2014 Q3	$6.33M	Sell	64,796 -106	-0.2%	-$10.4K	0.84%	42
2014 Q2	$6.54M	Sell	64,902 -6,685	-9%	-$652K	0.95%	36
2014 Q1	$6.57M	Sell	71,587 -1,338	-2%	-$123K	1.1%	38
2013 Q4	$6.6M	Sell	72,925 -1,792	-2%	-$155K	1.06%	36
2013 Q3	$5.96M	Hold	74,717	–	–	1.04%	38
2013 Q2	$5.44M	Buy	+74,717	New	+$5.59M	1%	38

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hourglass Capital's ZBH Position: Q1 2026 in Review

Hourglass Capital reduced its Zimmer Biomet (ZBH) stake by 0.12% in Q1 2026, selling an estimated $8.72K and leaving 78,055 shares worth $7.06M. The position accounts for 1.47% of the portfolio, ranked #31.

Hourglass Capital first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.79M in Q3 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Hourglass Capital held 78,055 shares of Zimmer Biomet worth $7.06M as of Q1 2026.
Hourglass Capital sold 95 Zimmer Biomet shares in Q1 2026, an estimated $8.72K.
Zimmer Biomet made up 1.47% of Hourglass Capital's portfolio in Q1 2026, its #31 holding.
Hourglass Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Hourglass Capital's Zimmer Biomet position peaked at $8.79M in Q3 2016.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Hourglass Capital's 13F filing for Q1 2026, filed 4 May 2026.